CJC-1295 (with DAC) 5mg

CJC-1295 with DAC is one of the most preferred peptides for stimulating the body's own production of growth hormone, known for its prolonged action and its ability to maintain stable levels of GH and IGF-1 for a long period of time.

What is CJC-1295 with DAC?

CJC-1295 with DAC is a synthetic peptide developed as an analogue of GHRH (Growth Hormone Releasing Hormone) – the hormone that controls the release of growth hormone in the body. Its main difference compared to other peptides is the DAC (Drug Affinity Complex) addition, which allows the molecule to bind to albumin in the blood and significantly extend its half-life.

Instead of a short-term effect, as with other peptides, CJC-1295 (with DAC) provides prolonged and stable stimulation of growth hormone, which can be maintained days after a single administration.

After administration, the peptide stimulates the pituitary gland to release growth hormone, leading to increased IGF-1, a key factor related to muscle growth, recovery, metabolism and body composition.

CJC-1295 (with DAC) provides prolonged stimulation of the natural release of growth hormone, without the need for frequent administration.

What are the benefits of CJC-1295 with DAC?

• Stimulation of growth hormone

CJC-1295 (with DAC) supports the natural release of GH, which is key for recovery and regeneration.

• Increase in IGF-1

It is associated with a stable increase in IGF-1, which is a major factor for muscle growth and recovery.

• Support for muscle growth

Stimulates processes related to building lean muscle mass.

• Improvement of body composition

Helps reduce fat and maintain a better physical balance.

• Accelerated recovery

Associated with faster recovery after physical exertion.

• Improvement of sleep

Positively influences sleep quality, which is key for hormonal balance.

• Tissue regeneration

Supports recovery processes in muscles, joints and connective tissue.

Clinical trials on CJC-1295 with DAC?

CJC-1295 has been the subject of clinical studies showing that the peptide can lead to a significant and prolonged increase in growth hormone and IGF-1 levels. In observed studies the effect is sustained days after a single administration, which distinguishes it from most other peptides in this category.

This sustained physiological response is the reason CJC-1295 (with DAC) is regarded as one of the most effective options for long-term GH stimulation in research.

Proper administration and dosage of CJC-1295 with DAC within a research protocol

CJC-1295 (with DAC) is typically administered via subcutaneous injection, and due to its extended half-life does not require daily dosing. In research protocols doses most frequently used range from 1 to 2 mg, administered one to two times per week.

One of its main advantages is achieving a stable effect with significantly less frequent administration compared to other peptides.

The duration of administration depends on the specific goals and the research protocol used.

Possible side effects of CJC-1295 with DAC?

CJC-1295 (with DAC) is generally well tolerated at proper dosages, with the most common reactions being mild and temporary such as water retention, slight redness at the injection site or a feeling of fatigue. Rarely, headaches or mild discomfort may occur, which usually resolve quickly.

Comparison of CJC-1295 with DAC with other peptides

CJC-1295 with DAC belongs to the group of GHRH analogues, which means it stimulates the pituitary gland to release growth hormone via GHRH receptors. DAC (Drug Affinity Complex) is a modification that extends the molecule's residence time in the body and provides prolonged action. This clearly distinguishes it from GH secretagogues, which work through ghrelin receptors by a different mechanism.

CJC-1295 with DAC vs Sermorelin

Both peptides are GHRH analogues. Sermorelin is shorter and closer to natural GHRH, with a shorter action and a more pulsatile profile. CJC-1295 with DAC is significantly longer-acting and maintains GH stimulation for a longer period.

CJC-1295 with DAC vs CJC-1295 without DAC

Both forms belong to the same group of GHRH analogues. CJC-1295 without DAC is shorter-acting and is often used for more physiological pulses. The DAC version provides a more stable and prolonged action with less frequent administration.

CJC-1295 with DAC vs Tesamorelin

Tesamorelin is also a GHRH analogue, but it was developed with a very strong effect on GH and IGF-1 and has been clinically used in specific medical contexts. CJC-1295 with DAC is more popular in research protocols aimed at recovery, body composition and anti-aging strategies.

CJC-1295 with DAC vs Ipamorelin

Ipamorelin belongs to the group of GH secretagogues and stimulates GH via ghrelin receptors (GHS-R1a), not via the GHRH receptor. CJC-1295 with DAC signals via the GHRH pathway, while Ipamorelin activates a parallel mechanism. This is why they are often combined.

CJC-1295 with DAC vs GHRP-2 and GHRP-6

GHRP-2 and GHRP-6 are also GH secretagogues. They typically produce a faster and more pronounced GH peak, but are shorter-acting. GHRP-6 is also known for strongly increasing appetite, while GHRP-2 has a stronger GH response. CJC-1295 with DAC is smoother and longer-lasting as a model.

CJC-1295 with DAC vs Hexarelin

Hexarelin is a potent GH secretagogue with an pronounced growth hormone peak and a strong receptor effect. CJC-1295 with DAC works more gradually and continuously via the GHRH mechanism. Hexarelin is a more aggressive signal, whereas CJC-1295 with DAC is a more stable and long-term approach.

CJC-1295 with DAC vs hGH (Somatotropin)

hGH (Somatotropin) is a direct exogenous growth hormone that enters the body ready-made. CJC-1295 with DAC does not deliver hormone from outside, but stimulates the body's own production of GH.

The information on this website has been collected and summarized from multiple scientific studies and analyses.

It is for informational purposes only and is not intended for diagnosis, treatment, or prevention of diseases.

The products offered on the site are not classified as drugs or medical devices and are suitable only for laboratory and scientific research purposes.